EP2464337B2 - Tablet Formulation of N-[2,4-Bis(1,1-Dimethylethyl)-5-Hydroxyphenyl]-1,4-Dihydro-4-Oxoquinoline-3-Carboxamide for Use in the Treatment of Cystic Fibrosis